chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain, Pain of skin
Clinical narrative: severe surface full body pain to the touch; It seemed as if my musclesweren't sore but everything on top of them was; skin was painful; so much severe pain unable to do anything for the remainder of the day; severe headache/head pain; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to azithromycin (MANUFACTURER UNKNOWN).  The patient did not receive any other medications within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 03:30, the patient experienced severe surface full body pain to the touch, it was seemed as muscles were not sore but everything on top of them was sore. The skin was painful to touch and the patient was in so much severe pain and unable to do anything for the remainder of the day. This also came along with a severe headache/head pain that has lingered since. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe surface full-body pain to the touch, muscles were not sore but everything on top of them was sore, skin painful, so much severe pain and unable to do anything for the remainder of the day, and severe headache/head pain were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort, Lymphadenopathy
Clinical narrative: Lump in armpit, it was hard and around the size of a large lima bean; Soreness in left armpit; Discomfort; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration on 17Apr2021 at 10:15 (at the age of 31-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Apr2021 at 00:00 hours, the day after the first vaccination, the patient experienced soreness in her left armpit. On 23Apr2021, six days out of the first dose, the patient had a lump in her armpit. It was hard and around the size of a large lima bean. After reading reports and side effect information of swollen lymph nodes she waited several days. The lump was gone by day 9 and the discomfort faded by 12 days after the first vaccine shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events of soreness in left armpit was recovered on an unknown date in 2021, the event of lump in armpit was recovered on 26Apr2021 for a duration of 3 days and for the event of discomfort was recovered on 29Apr2021 for a duration of 12 days.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Eye swelling, Fatigue, Mouth swelling
Clinical narrative: Swollen eyes; Swollen mouth; Joint pains; Fatigue; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable other healthcare professional. A 56-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 29Apr2021 (at an age of 56-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications of patient was not reported. It was unknown if the patient received medications within 2 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient was not tested for COVID-19. On 29Apr2021, 5 hours after vaccine, the patient had swollen eyes and mouth, joint pains, fatigue, nausea, vomiting and diarrhea. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events. The clinical outcome of the events of swollen eyes, mouth swelling, joint pains, fatigue, nausea, vomiting and diarrhea were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Swollen eyes; Swollen mouth; Joint pains; Fatigue; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable other healthcare professional. A 56-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 29Apr2021 (at an age of 56-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications of patient was not reported. It was unknown if the patient received medications within 2 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient was not tested for COVID-19. On 29Apr2021, 5 hours after vaccine, the patient had swollen eyes and mouth, joint pains, fatigue, nausea, vomiting and diarrhea. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events. The clinical outcome of the events of swollen eyes, mouth swelling, joint pains, fatigue, nausea, vomiting and diarrhea were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: red lump under injection site, painful to touch.; Injection site bruising; Red lump under injection site; red lump under injection site, painful to touch.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 05May2021 at 11:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications include multivitamins- one a day women's (MANUFACTURER UNKNOWN) since an unknown date for unknown indication. It was not reported whether the patient had allergies to medications, food, or other products.  The patient received medications within two weeks prior the vaccination. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 9:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 11:00, the patient experienced injection site bruising, red lump under injection site, painful to touch. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events injection site bruising, red lump under injection site, painful to touch were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Muscle spasms in right arm, not the arm where injection was made.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 10:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not have allergy to any medications, food, or other products. The patients past drug was reported as no. Concomitant medications taken within two weeks prior to the vaccination included ibuprofen (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 16:30, the patient experienced muscle spasms in right arm, not the arm where injection was made. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event.  The clinical outcome of the event muscle spasms in right arm, not the arm where injection was made was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gait inability, Hyperhidrosis, Nausea, Photophobia
Clinical narrative: Severe dizziness; Visual disturbances; Nauseous; Sweaty; first turned on my side, since I didn't want to rush to get up. When doing so with eyes opened, they flickered without me doing so.; Able to rise but had help walking and sitting; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 11Apr2021 at 10:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as various. The patient had known allergies. Concomitant medications included sotalol (MANUFACTURER UNKNOWN), warfarin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and magnesium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 19Mar2021 at 11:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 00:30, the patient awaked from sleep with severe dizziness, visual disturbances, also nauseous and sweaty, the patient first turned-on side, since didn't want to rush to get up, when doing so with eyes opened, they flickered without doing so. Finally able to rise but had help walking and sitting, the patient still experiencing dizziness/ vertigo since that evening with periodic episodes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe dizziness, visual disturbances, nauseous, sweaty, eyes flickered, unable to walk and sit without help, vertigo and included treatment with meclizine (MANUFACTURER UNKNOWN) from an unknown date. The clinical outcome of the events severe dizziness, visual disturbances, nauseous, sweaty, eyes flickered without doing so, able to rise but had help walking and sitting and vertigo were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo, Visual impairment
Clinical narrative: Severe dizziness; Visual disturbances; Nauseous; Sweaty; first turned on my side, since I didn't want to rush to get up. When doing so with eyes opened, they flickered without me doing so.; Able to rise but had help walking and sitting; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 11Apr2021 at 10:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as various. The patient had known allergies. Concomitant medications included sotalol (MANUFACTURER UNKNOWN), warfarin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and magnesium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 19Mar2021 at 11:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 00:30, the patient awaked from sleep with severe dizziness, visual disturbances, also nauseous and sweaty, the patient first turned-on side, since didn't want to rush to get up, when doing so with eyes opened, they flickered without doing so. Finally able to rise but had help walking and sitting, the patient still experiencing dizziness/ vertigo since that evening with periodic episodes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe dizziness, visual disturbances, nauseous, sweaty, eyes flickered, unable to walk and sit without help, vertigo and included treatment with meclizine (MANUFACTURER UNKNOWN) from an unknown date. The clinical outcome of the events severe dizziness, visual disturbances, nauseous, sweaty, eyes flickered without doing so, able to rise but had help walking and sitting and vertigo were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lethargy
Clinical narrative: Fatigue and lethargy; lethargy; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 25Apr2021 at 16:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 04Apr2021 at 13:15(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 27Apr2021 at 21:00, the patient experienced fatigue and lethargy. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event fatigue and lethargy was recovered on unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Crying, Fatigue, Headache
Clinical narrative: uncontrolled crying; I was fatigued; had the chills. (both doses); I have a persistent headache on the right side.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and pravastatin sodium (PRAVACHOL) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 the patient experienced Emotional reaction - uncontrolled crying (both doses) she was fatigued and had the chills (both doses) she had a persistent headache on the right side. No therapeutic measures were taken as a result of the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events uncontrolled crying, fatigued, chills and persistent headache were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Crying, Fatigue
Clinical narrative: uncontrolled crying; I was fatigued; had the chills. (both doses); I have a persistent headache on the right side.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and pravastatin sodium (PRAVACHOL) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 the patient experienced Emotional reaction - uncontrolled crying (both doses) she was fatigued and had the chills (both doses) she had a persistent headache on the right side. No therapeutic measures were taken as a result of the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events uncontrolled crying, fatigued, chills and persistent headache were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain
Clinical narrative: muscle ache at site of injection; very tired; This is a spontaneous report from a contactable other healthcare professional, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included seafood allergy. The patient received unspecified medications within two weeks of vaccination. The patient previously took augmentin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:00, the patient experienced muscle ache at site of injection which lasted for 2 days and very tired. The patient did not receive any treatment for the reported events. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of injection site muscle pain was recovered on 08Apr2021 while the clinical outcome of tiredness was recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Extreme vertigo; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 30Apr2021 at 14:45 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not had any relevant medical history and known allergies. Concomitant medications included ibuprofen (ADVIL) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 21:00, the patient experienced extreme vertigo. Therapeutic measures were taken as a result of the event of extreme vertigo and included treatment with upper cervical chiropractor. The adverse event resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the event of vertigo was recovering at the time of  this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pyrexia
Clinical narrative: Sore shoulder; Fatigue; Feverish lasting about five hours; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8733) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced sore shoulder, fatigue and feverish lasting about five hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore shoulder, fatigue and feverish lasting about five hours was recovered on an unknown date in 2021.    No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Vitiligo
Clinical narrative: Vitiligo on both of hands and face; This is a spontaneous report from a contactable physician. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via intramuscular route of administration in the left arm on 19Mar2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via intramuscular route of administration in the left arm on 13Apr2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient had vitiligo on both of his hands and his face. It was reported that he did not have this problem prior to vaccination. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included an unspecified treatment. The clinical outcome of the event vitiligo on both of hands and face was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste directly after, lasted all day; This is a spontaneous report from a contactable consumer, the patient. A 36-years-old non-pregnant female patient received an unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 14Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to latex. Concomitant medications included intrauterine contraceptive device (IUD) used for unknown indication, from unspecified dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced metallic taste directly after which lasted all day. No therapeutic measures were taken as a result of reported events. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. The clinical outcome of the event metallic taste recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash covering both arms; This is a spontaneous report from a non-contactable nurse. A 24-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 31Mar2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 01Apr2021, next day after the first dose, the patient experienced rash covering both the arms. Therapeutic measures were taken as a result of the event and included treatment with hydrocortisone cream and ice packs. The clinical outcome of the event rash covering both arms was resolved on 02Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives all over abdomen, back, bottom,legs, arms, neck; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02May2021 at 12:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis, migraine and COVID-19. The patient was allergic to penicillin and latex. Concomitant medications included norethisterone (NORETHINDRONE), spironolactone (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL) all from unknown date for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 12:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 14:00, the patient experienced hives all over abdomen, back, bottom, legs, arms and neck. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event hives all over abdomen, back, bottom, legs, arms, and neck was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: hands had mild swelling; intermittent tingling in the thumb and forefinger; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: fr8730) via an unspecified route of administration in the left arm on 27Mar2021 at 16:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as allergies to penicillin allergy, possible shellfish allergy. No concomitant medication was reported. The patient previously received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6199) via an unspecified route of administration in the left arm on 06Mar2021 at 16:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On an unknown date in Apr2021, the patient experienced approximately 2 weeks after the 2nd shot hands had mild swelling and intermittent tingling in the thumb and forefinger that continues to be an ongoing problem, the patient had not seen a doctor yet but planning to make an appointment in next few days. No therapeutic measures were taken as a result of the adverse events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hands had mild swelling, intermittent tingling in the thumb, intermittent tingling in the forefinger was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Muscular weakness, Pyrexia
Clinical narrative: I had a low grade feverstarting around 2-3 hours after mysecond vaccine, which quickly rose toaround 103 about 14 hours after myvaccination; Full body chills; Muscle weakness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04May2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The had no known allergies. Concomitant medications included colecalciferol (VITAMIN D3) (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) all for unknown indication, from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 16:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021 at 23:30 the patient experienced high fever (103 degree Fahrenheit), full body chills, muscle weakness, sore arm, headache. He had a low-grade fever starting around 2-3 hours after his second vaccine, which quickly rose to around 103 about 14 hours after his vaccination, where it stayed for around 3 hours. He took 500 milligrams of acetaminophen when his fever rose but it did not reduce it below 103.The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of high fever, full body chills, muscle weakness, sore arm, headache and included treatment with acetaminophen 500 milligrams from unspecified start date to unspecified stop date. On 04May2021, patient underwent lab tests and procedures, which included, body temperature and the result was 103 Degrees Fahrenheit. The clinical outcome of the events fever, full body chills, muscle weakness, sore arm and headache was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance
Clinical narrative: About t25 minutes after receiving second shot, my right hip replacement area became very painful.  It was difficult to walk for a few hours.  The next day I could walk but entire hip area was painful.; About t25 minutes after receiving second shot, my right hip replacement area became very painful.  It was difficult to walk for a few hours.  The next day I could walk but entire hip area was painful.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 05May2021 at 12:15 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not have any known allergies. Concomitant medications were unspecified. The patient also received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 12:45, the patient experienced about 25 minutes after receiving second shot, her right hip replacement area became very painful.  It was difficult to walk for a few hours.  The next day the patient could walk but entire hip area was painful. The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events pain in hip (right hip replacement area) and walking difficulty was recovering.   No follow-up attempts are possible; Information on lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Cyst, Menstrual disorder, Menstruation delayed, SARS-CoV-2 test
Clinical narrative: Abnormal menstrual cycle.; Ultrasound finds large cysts; Late one month by 5 days, then Arrived two weeks late- otherwise always 28 days.; This is a spontaneous report from a contactable physician. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Feb2021 at 11:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09 Jan2021 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, the patient experienced abnormal menstrual cycle, late one month by 5 days, then arrived two weeks late otherwise always 28 days and ultrasound finds large cysts. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 10Apr2021, the patient underwent nasal swab color test and the result was negative. The clinical outcome of the events abnormal menstrual cycle, late one month by 5 days, then arrived two weeks late otherwise always 28 days and ultrasound finds large cysts were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Intermenstrual bleeding, Muscle spasms
Clinical narrative: Feeling cramps and bloating; Feeling cramps and bloating; Extreme cramping and bloating and some spotting. I dont normally bleed during my period because I have the Mirena IUD; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 01Mar2021 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received  first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00, the patient experienced period cycle symptoms which lasted as usual for 3-7 days. The patient started feeling period symptoms again on 08Apr2021 and had been feeling that since long. The patient's period cycle  was usually in the beginning of the month. On 26Apr2021, the patient started spotting again, feeling cramps and bloating. The patient had period symptoms for a full month. Extreme cramping and bloating and some spotting. The patient had Mirena IUD and hence do not normally bleed during period. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events spotting menstrual, cramps and bloating was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urticaria
Clinical narrative: Hives on torso, arms, and legs; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 10Apr2021 at 09:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos disease and high cholesterol. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 20Mar2021 at 09:45 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 09:30 the patient experienced hives on torso, arms, and legs. On 13Apr2021, the patient underwent (COVID 19 virus test) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of hives on torso, arms, and legs and included treatment with Benadryl (MANUFACTURER UNKNOWN) on her own on an unknown date.  The clinical outcome of the event hives on torso, arms, and legs was resolved on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Flatulence, Nausea
Clinical narrative: Nausea; pale diarrhea; gas; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 16:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, hashimoto's thyroiditis from an unspecified date. The patient had no known allergies. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), insulin degludec (TRESIBA), insulin lispro (HUMALOG) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 06:00 the patient experienced nausea, gas, and pale diarrhea still 4 days after 2nd dose. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, diarrhea, gas was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Inappropriate schedule of product administration
Clinical narrative: fatigue; itchy small bumps on stomach and back; itchy small bumps (hives) on stomach and back; fever; chills; sore muscles; sore/stiff joints; sore/stiff joints; headache; nausea; fatigue; swollen lymph nodes in shot arm; inappropriate schedule of vaccine administration; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation (Inappropriate schedule of vaccine administered). The patient had no medical history. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. On 19Apr2021 at 06:00, the patient experienced fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue and swollen lymph nodes in the arm. On 20Apr2021, the patient experienced fatigue, headache, hives, itchy small bumps on the stomach and back. The patient did not receive any treatment for the reported events. The adverse event did not result in a doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue, swollen lymph nodes in the arm, fatigue, headache, itchy small bumps on stomach and back and hives were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about the lot number cannot be obtained.